- Home
- RYET vs SOPH Comparison
RYET vs SOPH Comparison
Compare RYET & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYET
- SOPH
- Stock Information
- Founded
- RYET 2012
- SOPH 2011
- Country
- RYET China
- SOPH Switzerland
- Employees
- RYET N/A
- SOPH N/A
- Industry
- RYET
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RYET
- SOPH Health Care
- Exchange
- RYET NYSE
- SOPH Nasdaq
- Market Cap
- RYET 206.2M
- SOPH 219.8M
- IPO Year
- RYET 2025
- SOPH 2021
- Fundamental
- Price
- RYET $19.66
- SOPH $3.62
- Analyst Decision
- RYET
- SOPH Buy
- Analyst Count
- RYET 0
- SOPH 1
- Target Price
- RYET N/A
- SOPH $7.00
- AVG Volume (30 Days)
- RYET 458.1K
- SOPH 169.3K
- Earning Date
- RYET 01-01-0001
- SOPH 08-05-2025
- Dividend Yield
- RYET N/A
- SOPH N/A
- EPS Growth
- RYET N/A
- SOPH N/A
- EPS
- RYET N/A
- SOPH N/A
- Revenue
- RYET $6,989,985.00
- SOPH $67,173,000.00
- Revenue This Year
- RYET N/A
- SOPH $16.07
- Revenue Next Year
- RYET N/A
- SOPH $22.94
- P/E Ratio
- RYET N/A
- SOPH N/A
- Revenue Growth
- RYET N/A
- SOPH 4.66
- 52 Week Low
- RYET $2.68
- SOPH $2.58
- 52 Week High
- RYET $21.00
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- RYET N/A
- SOPH 70.98
- Support Level
- RYET N/A
- SOPH $2.81
- Resistance Level
- RYET N/A
- SOPH $3.40
- Average True Range (ATR)
- RYET 0.00
- SOPH 0.30
- MACD
- RYET 0.00
- SOPH 0.07
- Stochastic Oscillator
- RYET 0.00
- SOPH 98.31
About RYET RUANYUN EDAI TECHNOLOGY INC
Ruanyun Edai Technology Inc is primarily engaged in providing online academic exercise question banks with A.I. capabilities, online classes and homework, and on-demand lectures and evaluations that cover all K-12 subject fields and grade levels.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.